 |
Coagulation factor IX (recombinant), Fc fusion protein |
|---|---|
| Trade Name | Alprolix |
| Orphan Indication | Hemophilia B |
| USA Market Approval | USA |
| USA Designation Date | 2008-10-30 00:00:00 |
| Sponsor | Bioverativ Therapeutics, Inc.;225 2nd Avenue;Waltham, Massachusetts, 02451 |
